385 new COVID-19cases reported in Goa today, taking the total number of positive cases in the state to 13,484 including 3,809 active cases, 9,540 recovered cases and 135 deaths.
Coronavirus India News LIVE Updates: Today is the 151st day since India implemented a nationwide lockdown, to help curb the novel coronavirus pandemic. So far, India has recorded 29,05,823 confirmed COVID-19 cases, including 54,849 deaths. Maharashtra, Tamil Nadu and Andhra Pradesh have reported the highest number of cases. However, infections are rising rapidly in states like Karnataka, Uttar Pradesh and West Bengal. Yet, India’s recovery rate continues to rise and now stands at 74.3 percent. 'Unlock 3.0' is underway. Globally, there have been over 2.27 crore confirmed cases of COVID-19. More than 7.92 lakh people have died so far. Catch the latest updates here:
385 new COVID-19cases reported in Goa today, taking the total number of positive cases in the state to 13,484 including 3,809 active cases, 9,540 recovered cases and 135 deaths.
COVID-19 impact: Indoor Amusement Centres seek govt help as losses climb to Rs 1,000cr
Indoor Amusement Centres (IACs) that have been shut for over five months due to the coronavirus-led lockdown are seeking help from the government to reopen.
Shopping Centres Association India (SCAI), the association of mall owners in India and the Indian Association of Amusement Parks and Industries (IAAPI), the apex body representing the interests of Amusement Parks, Theme Parks, Water Parks and Indoor Amusement Centre in India, have written a letter to Home minister Amit Shah, highlighting the losses indoor amusement parks are incurring and the job losses in the sector.
Rajasthan reports 1,335 new COVID-19 cases and 12 deaths today, taking total cases to 67,954, including 14,525 active cases and 933 deaths.
1,406 new COVID-19 cases, 1,235 recoveries and42 deaths reported in Mumbai today. Total number of positive cases increase to 1,34,223 in Mumbai, including 18,297 active cases, 1,08,268 recovered cases and7,353 deaths.
Hong Kong will offer free coronavirus tests to its residents starting September1 as it grapples with its worst outbreak since the pandemic began, leader Carrie Lam said.
The testing program, which will last up to two weeks, will allow every Hong Kong resident to be tested on a voluntary basis, she said.
"For the good of yourself and others, and for safeguarding public health, please take part in the scheme," Lam said.
447 new COVID-19cases, 243 treated/cured cases reported in Uttarakhand today. Total positive cases in the state stand at 14,043 including 4,164 active cases, 9,676 recovered and192 deaths.
Senior Madhya Pradesh minister Gopal Bhargava has said that he has tested positive for COVID-19.
Karnataka reports 7,571 cases (2,948 in Bengaluru), 6,561 discharges and 93 deaths, taking total cases to 2,64,546 including 1,76,942 discharges and 4,522 deaths.
Delhi reports 1,250 new COVID-19positive cases, 1,082 discharges/recoveries and 13 deaths. Total number of cases now at 1,58,604 including 1,42,908 recovered cases, 11,426 active cases and4,270 deaths.
Delhi Disaster Management Authority (DDMA) issues order for re-opening of hotels in the national capital, except in containment zones; Standard Operating Procedure (SOPs) issued by Centre to be followed.
1,983 new COVID-19cases, 1,419 recoveries and12 deaths reported in Kerala in the last 24 hours. There are 18,673 active cases and 35,247 have recovered so far.
Tocilizumab may improve survival in sickest COVID-19 patients, scientists say
Tocilizumab, a drug normally used in rheumatoid arthritis and cancer treatments, may improve hospital survival in critically-ill COVID-19 patients admitted to the intensive care unit (ICU), according to an observational study of more than 600 people infected with the novel coronavirus.
The research, published in The Lancet Rheumatology, noted a roughly 36 percent decrease in hospital-related mortality among the ICU patients who received tocilizumab, as compared with patients in the ICU who didn't receive it.
They said Tocilizumab binds and blocks the interleukin (IL)-6 receptor, and helps damper the inflammatory response.
